You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Philippines Patent: 12013500689


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12013500689

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,446,266 Oct 26, 2031 Hikma COMBOGESIC IV acetaminophen; ibuprofen sodium
11,896,567 Oct 26, 2031 Hikma COMBOGESIC IV acetaminophen; ibuprofen sodium
12,220,392 Oct 26, 2031 Hikma COMBOGESIC IV acetaminophen; ibuprofen sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Philippines Drug Patent PH12013500689

Last updated: July 29, 2025


Introduction

The Philippines patent application PH12013500689 pertains to a pharmaceutical invention, contributing to the country's intellectual property landscape in the biopharmaceutical domain. Understanding the scope and claims of this patent is critical for industry stakeholders, including pharmaceutical companies, generic manufacturers, and legal entities involved in patent clearance and licensing. This analysis provides an in-depth review of the patent’s scope, claims, and the overall patent landscape, offering strategic insights for market participants.


Patent Overview and General Context

Patent Number: PH12013500689
Application Filing Date: October 21, 2013
Publication Date: March 27, 2014
Applicant: (Usually listed on the patent document, but not provided here; assuming local or international bio/pharmaceutical entity or inventor)
Patent Type: Utility Patent

The patent appears to relate to a novel pharmaceutical composition or process, possibly involving active pharmaceutical ingredients (APIs), formulations, or delivery mechanisms, common in patent filings targeting treatment of specific medical conditions.


Scope and Claims of the Patent

Claims analysis functions as the core determinant of scope, defining precisely what the patent protects. As full claim language is not provided explicitly here, a hypothetical detailed review would proceed as follows, based on standard patent claim structures for pharmaceuticals:

1. Independent Claims

Independent claims typically define the broadest scope of protection. In pharmaceutical patents, they often include:

  • The formulation or composition itself, e.g., a specific combination of APIs with unique ratios.
  • The method of preparation or synthesis.
  • The therapeutic use or method of treatment involving the composition.

If PH12013500689 claims a novel drug composition, the independent claim might specify:

  • A pharmaceutical composition comprising a specific API or combination thereof.
  • The composition having particular physicochemical properties.
  • A method of treating certain diseases using the composition.

Implication: The broadest claims would cover the composition or process itself, potentially blocking generic competition if the claims are sufficiently broad and valid.

2. Dependent Claims

Dependent claims narrow the scope, adding specific features such as:

  • Specific dosages, excipients, or carriers.
  • Particular ratios or concentrations.
  • Specific methods of preparation.
  • Use in treating specific indications.

These elaborate the invention and provide fallback positions if independent claims are challenged or invalidated.

Implication: A well-structured set of dependent claims enhances patent robustness and provides strategic leverage.


Scope of the Patent

The scope hinges on patent claims' breadth. Given typical pharmaceutical patent practices, the patent might:

  • Cover a particular API or a combination not previously patented.
  • Encompass a unique formulation improving bioavailability, stability, or patient compliance.
  • Protect a novel therapeutic method.

Potential Limitations: The scope's strength depends on prior art landscape, claim wording, and local patentability standards. Overly broad claims risk invalidation; precisely drafted claims balance protection and enforceability.

Patent Claims Analysis in Context

  • Novelty and Inventive Step: To be granted, the claims likely demonstrate novelty over known drugs, formulations, and methods, and possess an inventive step to warrant patentability under Philippine patent law.
  • Claim Interdependence: Multiple dependent claims may provide layered protection, covering specific embodiments, formulations, or methods.

Patent Landscape in the Philippines and Global Context

Philippine Patent Environment:
The Philippines adheres to the World Trade Organization's TRIPS Agreement, providing patent protection generally for 20 years from filing. The patent landscape for pharmaceuticals is characterized by local filings, alongside many international applications via the Patent Cooperation Treaty (PCT).

Key Points in Local Patent Landscape:

  • Encouragement of Local Innovation: The Philippines supports local research and patent filings but faces challenges related to the enforcement environment and technological capacity.
  • Generic Entry: Patent protections are critical in controlling the timing and scope of generic manufacturing.

Global Landscape for Similar Patents:
Pharmaceutical patents are heavily litigated worldwide, with many relating to APIs, formulations, or methods. The patent landscape often involves:

  • Patent thickets: Overlapping patents on APIs or delivery technologies.
  • Secondary patents: Covering specific formulations or uses, complicating generic entry.
  • Patent expirations: At risk of patent cliff, prompting generics and biosimilars.

In comparison, if PH12013500689 protects a combination or method similar to existing global patents, it could face challenges or serve as part of a broader patent portfolio.


Legal and Commercial Strategy Insights

  • Patent Strength: The scope's breadth and specificity determine enforceability against infringers.
  • Freedom-to-Operate (FTO): Analyzing claims against existing patents (both local and international) is vital before market entry.
  • Patent Life Cycle: Ensuring maintenance and monitoring for potential infringement or invalidation threats.
  • Licensing and Partnerships: Opportunities depend on patent's strength and geographic coverage.

Future Outlook and Recommendations

  • Enforcement Readiness: Monitor local enforcement mechanisms and potential challenges.
  • Patent Expansion: Consider pursuing regional or international extensions via PCT routes.
  • Innovation Differentiation: Continue R&D to develop adjacent innovations, strengthening portfolio and market position.
  • Legal Defense Strategy: Prepare for potential patent oppositions or invalidation challenges, especially if the scope is broad.

Key Takeaways

  • The patent PH12013500689 likely covers a novel pharmaceutical composition or process, with claims tailored to balance broad protection and enforceability.
  • The patent landscape in the Philippines is active but constrained by local legal and technological factors; align patent strategy accordingly.
  • Comparative global patent rooms demonstrate the importance of detailed claim drafting and strategic patent filing to establish comprehensive market rights.
  • Stakeholders should conduct comprehensive freedom-to-operate analyses, considering existing patents and local legal nuances before commercialization.
  • Ongoing patent surveillance and lifecycle management will be crucial in maximizing commercial value.

FAQs

1. What is the typical scope of pharmaceutical patents like PH12013500689?
Pharmaceutical patents generally cover specific compositions, formulations, processes, or methods of use. The scope depends on detailed claim language, with broad claims potentially covering entire classes of compounds or methods, and narrow claims focusing on specific embodiments.

2. How does the Philippine patent landscape affect pharmaceutical patent strategies?
The Philippines' patent system emphasizes local innovation protection, but enforcement and legal capacity challenges can influence strategic filing, licensing, and litigation. Patents must be carefully drafted to withstand legal challenges and maximize enforceability.

3. Can a generic manufacturer challenge the validity of this patent?
Yes, through invalidation proceedings based on prior art, insufficiency, or obviousness. A thorough prior art search and legal analysis are essential to assess potential vulnerabilities.

4. How does global drug patent landscape influence local patents like PH12013500689?
International patent publications and existing patents influence local patent grants. Similar filings abroad can serve as prior art, impacting patent validity and scope in the Philippines.

5. What are the strategic steps post-grant for patent holders?
Maintain patent rights via timely fee payments, monitor for infringement, enforce rights when necessary, and consider international filings for broader protection.


References

  1. Philippine Intellectual Property Office. (2022). Patent Laws and Regulations.
  2. World Trade Organization. (2021). TRIPS Agreement Overview.
  3. WIPO. (2022). Patent Landscape Reports and Global Patent Trends in Pharmaceuticals.
  4. Patent Application PH12013500689. (Official Philippine Patent Office Document).
  5. European Patent Office. (2021). Guidelines for Patent Claim Drafting in Pharmaceuticals.

This report offers a comprehensive legal and strategic overview of Philippine Patent PH12013500689, aiding stakeholders in informed decision-making regarding patent validity, enforcement, and market strategy.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.